Finding new-and-improved treatments

diabetes endo 7

At Children’s, we focus on research and innovations that make a difference at the bedside. From improving day-to-day quality of life for children and teens, to developing new treatment approaches and adopting cutting-edge technologies, our research is completely focused on children and their families.

Children’s is engaged in many types of research, including investigator-initiated studies (led by a Children’s clinician) as well as externally sponsored multi-center trials, observational studies and registries.

Research studies are ongoing in all areas of the hospitals and clinics, but read more about diabetes and endocrine disorder research below.

  • “The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents with Severe Obesity: a Randomized, Placebo-Controlled, Clinical Trial.” Archives of Pediatric and Adolescent Medicine. April 2013.
  • “Cases of Congenital Adrenal Hyperplasia Missed by Newborn Screening in Minnesota.” JAMA. June 2012.
  • “Exenatide as a Weight-Loss Therapy in Extreme Pediatric Obesity: a Randomized, Controlled Pilot Study.” Obesity. February 2012.

We share our outcomes with you

Choosing where to bring your child for care is a major decision. We understand you want all the information you can get. And you want it in a clear, straightforward form that helps you make the right choice for your family.

That's why we share our outcomes with you. In medicine, "outcomes" measure the end results of a treatment. By comparing our outcomes with those of other hospitals, locally and nationally, you can see how we rank in terms of keeping patients safe and healthy.

See how Children's ranks on six quality of care measures. Learn more »


LEARN MORE ABOUT OUR DIABETES AND ENDOCRINOLOGY PROGRAM

Why Children's
Conditions and services
Meet the team What to expect
Resources Locations/Contact us Health professionals